MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 39 filers reported holding MUSTANG BIO INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 278 | +31.1% | 0.00% | – |
| Q4 2022 | $0 | – | 212 | -58.8% | 0.00% | – |
| Q3 2022 | $0 | – | 515 | +347.8% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 115 | -97.5% | 0.00% | – |
| Q1 2022 | $5,000 | -80.8% | 4,574 | -70.2% | 0.00% | – |
| Q4 2021 | $26,000 | +4.0% | 15,331 | +69.0% | 0.00% | – |
| Q3 2021 | $25,000 | +47.1% | 9,074 | +76.0% | 0.00% | – |
| Q2 2021 | $17,000 | -39.3% | 5,155 | -37.0% | 0.00% | – |
| Q1 2021 | $28,000 | -34.9% | 8,189 | -27.3% | 0.00% | – |
| Q4 2020 | $43,000 | – | 11,260 | +18666.7% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 60 | -94.8% | 0.00% | – |
| Q1 2020 | $3,000 | -50.0% | 1,146 | -27.6% | 0.00% | – |
| Q4 2019 | $6,000 | +50.0% | 1,582 | +16.1% | 0.00% | – |
| Q3 2019 | $4,000 | 0.0% | 1,363 | +101.9% | 0.00% | – |
| Q3 2018 | $4,000 | – | 675 | +4118.8% | 0.00% | – |
| Q2 2018 | $0 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 125,000 | $336,000 | 0.45% |
| Spotlight Asset Group, Inc. | 305,312 | $821,000 | 0.41% |
| GSA CAPITAL PARTNERS LLP | 560,215 | $1,507,000 | 0.15% |
| Ikarian Capital, LLC | 506,033 | $1,360,000 | 0.10% |
| EMFO, LLC | 31,000 | $83,000 | 0.07% |
| Bridgewater Advisors Inc. | 45,000 | $121,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 253,275 | $682,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 294,300 | $792,000 | 0.02% |
| TWO SIGMA ADVISERS, LP | 1,235,200 | $3,323,000 | 0.01% |
| Cypress Capital Management LLC (WY) | 2,950 | $8,000 | 0.01% |